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Computer analysis of the intrinsic membrane protein, myelin proteolipid, shows strong sequence similarities 
between the putative xtramembranc segments of the proteolipid protein and a number of viral proteins, 
several of which infect humans. These similarities are even more striking than those reported previously 
between viral proteins and the encephalitogenic myelin basic protein (MBP). These findings, along with 
other reports of molecular mimicry by viruses, suggest that immunological cross-reactions between virus- 
induced antibodies or T-cells and analogous antigenic determinants (epitopes) in myelin protcolipid could 
be involved in the pathophysiology of multiple sclerosis or post-infectious dcmyclinating syndromes. 
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1. INTRODUCTION 
Current evidence suggests that the etiology of 
multiple sclerosis and other demyelinating diseases 
involves a combination of viral and autoimmune 
factors [1]. A particularly well studied model for 
multiple sclerosis is EAE which can be induced by 
immunization of laboratory animals with CNS 
tissue or with MBP, one of the major myelin pro- 
teins [2]. Recently it has been reported that MBP 
shows homology with certain viral proteins [3]. 
Furthermore, immunization with peptides having 
regions common to MBP and hepatitis B virus 
DNA polymerase showed histological EAE in rab- 
bits [4]. However, it has long been recognized that 
components other than MBP contribute to the 
encephalitogenic response to CNS tissue [5]. 
* To whom correspondence should be addressed 
Abbreviations: MBP, myelin basic protein; EAE, ex- 
perimental allergic encephalomyelitis; CNS, central ner- 
vous system; MLV, murine leukemia virus; AIDS, 
acquired immune deficiency syndrome; HTLV- 
III/LAV, human T-lymphotropic retrovirus 
The most abundant protein of CNS myelin is 
myelin proteolipid protein, which is embedded in 
the myelin membrane. Its amino acid sequence has 
been reported recently [6,7], and two different 
models have been proposed for its conformation i  
the myelin membrane [8,9]. Immunization of rab- 
bits with the proteolipid apoprotein leads to the 
development of a chronic, progressive or relapsing 
form of EAE [10]. However, the epitopes in 
myelin proteolipid which canse the encephalito- 
genic response are not known. 
In the present study we compared decapeptide 
sequences from proposed [8,9] extramembrane 
hydrophilic regions of myelin proteolipid with 
various viral proteins by computer analysis, with 
the aim of searching for similarities, such as found 
between MBP and viral proteins, that might shed 
light on the origin of demyelinating diseases. 
2. METHODS 
Decapeptides were chosen for comparison with 
the extramembrane s gments of the proteolipid 
protein, the rationale being that decapeptides are 
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more than sufficient o induce an immune response 
[11] and that epitopes of membrane proteins are 
generally located at extramembrane hydrophilic 
regions. Comparisons and statistical scorings were 
made using the database (release 6.8 of 28 August 
1985, containing 3309 sequences) and programs of 
the Protein Identification Resource of the National 
Biomedical Research Foundation. The search pro- 
gram compared every decapeptide in bovine brain 
myelin proteolipid with every decapeptide in the 
database. The calculation of similarity scores was 
accomplished using the Mutation Data Matrix [12] 
program. For each proteolipid decapeptide, 
709253 comparisons were made and the highest 
scoring segments and their standard deviations 
were printed out. We selected those viral decapep- 
tides, similar to extramembrane hydrophilic 
segments of myelin proteolipid, with scores higher 
than 30, and which also exceed the average by 5 
standard deviations; i.e., the probability that the 
match is due to random chance is <3 x 10 -7 . A 
VAX 11/750 computer was used for searching and 
calculations. 
3. RESULTS AND DISCUSSION 
Sequence alignments with scores of 30 or greater 
were observed between proteolipid and 249 viral 
decapeptides, excluding identities seen with pro- 
teins from similar strains of virus. These include 
decapeptides from a variety of types of viruses, 
such as adenoviruses and Epstein-Barr, influenza 
and measles viruses. Only those with a score of 38 
or greater, or which show at least 60% identity are 
shown in table 1. The degree of similarity between 
proteolipid and viral proteins is significantly 
greater than that observed [3] between MBP and 
viral proteins. Furthermore, although only 10% of 
the proteins in the protein sequence database are 
viral proteins, they account for over 30% of the 
similarities. 
It is interesting and perhaps significant that 
many of the strong similarities lie between residues 
135 and 150 in the proteolipid. This region is 
predicted (Shaw, S.-Y., unpublished) to have a 
strong tendency to form an amphipathic helix 
(hydrophobic on one side and polar on the other), 
and thus might be regarded as a prime candidate 
for an antigenic site. Likewise, many similarities 
are found with the N-terminus of the proteolipid, 
a region which has also been predicted to be an am- 
phipathic helix [8l. 
The two proposed models [8,9] for the organiza- 
tion of the proteolipid in the myelin membrane are 
Table 1 
Comparison of myelin proteolipid ecapeptide s quences with those of certain viral proteins 
Protein Virus Residues Sequence Score 
Proteolipid 
Late 100 kDa 
Structural poly- 
protein 
Coat protein gp37 
Middle T antigen 
Probable DNA 
polymerase 
Ribonucleotide 
reductasc 
Hypothetical 
BHLF1 
Proteolipid 
Probable gag-pol 
polyprotein 
P3 
Adenovirus 
1- 14 GLLECCARCLVGAP 
561- 570 G L LL E_.C_ HC R C N 
Sindbis virus 
Rous sarcoma 
Mouse 
polyomavirus 
Woodchuck 
hepatitis 
782- 791 V L_ MRCCS CCL  
201- 210 LLVVCLPCLL  
137- 146 K CD_A R..C L_____VL G 
767- 776 A(TLARCWTGA 
Epstein-Barr 409- 418 C LP R._CL. ENAP 
Epstein-Barr 19- 28 C_P P P CLP  GAP 
31- 57 FCGCGHEALTGTEKL I  ETYFS  KNYQDY 
Human adult 
T-cell leukemia 1038-1047 F T HCGQT A_L__! 
Human in- 
fluenza A 522- 53t QGTEKLT I  TY  
(43) 
(47) 
(38) 
(34) 
(31) 
(43) 
(4O) 
(36) 
(33) 
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Protein Virus Residues Sequence Score 
Hypothetical Mouse roam- 
protein A-198 mary tumor 183- 192 L I E t lYS  AKT  Y (37) 
Genome protein Human 
rhinovirus 917- 926 VYYS TYY  RKY  (38) 
Proteolipid 96-  108 VRQi  F GDYKTT I C 
El-glycoprot ein 
136- 145 VRP I  I EDYHT 
Envelope 
18- 27 I FGDYS PS CC 
Proteolipid 118- 127 GGQKGRGS RGQH 
Probable nuclear 
antigen 326- 335 GGGRGRGGS G 
Hypothetical 
ORF-1 178- 187 QKTKGHRGS H 
Proteolipid 135- 153 ERVCHCLGKWLGt lPDKF  VG 
Hypothetical 
BGLF1 Epstein-Barr 34- 43 NRVP NCEGAW (40) 
Neuraminidase Human in- 
fluenza A 
(strain 
A/PR/8/34) 289- 298 MC V C R D N WHG (43) 
Neuraminidase Human in- 
fluenza A 
(strain 
A/NT/60/68) 289- 298 C 1 C R D N W K G S (39) 
Middle T antigen Hamster 
polyomavirus 150- 159 DCFALWFGLP (41) 
Small T antigen Mouse 
polyomavirus 152- 161 ECYMQWF GTp (39) 
Probable L1 Cottontail rab- 
protein bit papilloma- 
virus 2- 11 AVWLS TQNKF (38) 
Probable DNA Squirrel 
polymerase hepatitis 623- 632 K WWG HT L H F M (38) 
Genome Foot and 
polyprotein mouth disease 1140-1149 W1 A S E E K F_V T (391 
Core antigen Duck hepa- 
titis B 214- 223 W_LS TpEKYRG (47) 
Proteolipid 224- 233 LS I CKTAEF  QMT 
34 kDa Simian 11 
rotavirus 282- 291 LE I  CKKL  LFQ (36) 
33 kDa Bovine 
rotavirus 282- 291 L DI CKKL  L FQ (36) 
Kinase-related 
transtbrming 
protein Rous sarcoma 399- 408 V C K V A D F G k A (39) 
Murine 
coronavirus (321 
Human adult 
T-cell leukemia (44) 
Epstein-Barr (34) 
AIDS (32) 
All of the peptides hown have alignment scores of 38 or greater and/or have at least 6 identities. Amino acids which 
are identical with the corresponding residues in the proteolipid are underlined 
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similar in that they depict the protein as threading 
through the lipid bilayer several times with the 
polar segraents external to the bilayer; they differ, 
however, in the sidedness of some of the ex- 
tramembrane segments. While both models put 
residues 1-10 and 220-235 on the extracellular 
face of the membrane, the model of Laursen et al. 
[8] puts residues 35-60 on the extracellular face 
and 90-150 on the cytoplasmic face, whereas the 
model of Stoffel et al. [9] predicts the opposite 
orientation for the latter two segments. Regardless 
of which (if either) model is correct, similarities 
between viral proteins and proposed extracellular 
and cytoplasmic segments of the proteolipid are 
seen. 
It has been proposed [3,4] that EAE-like 
diseases can arise when virus-evoked antibodies 
and/or  sensitized T-cells cross-react with 
homologous amino acid sequences (epitopes) in 
MBP. However, since MBP is located entirely on 
the cytoplasmic face of the membrane and is 
therefore within the oligodendroglial cell, it would 
be expected to be relatively inaccessible to immune 
surveillance. On the other hand, the proteolipid 
has potential antigenic sites not only on the 
cytoplasmic face but also on the outer surface of 
the membrane. Recognition of these sites by an- 
tivira[ antibodies or sensitized cells could induce a 
cascade of immunological events leading to cell 
destruction. In the process, MBP would be re- 
leased, which might result in further inflammatory 
consequences. 
The similarities between MBP and virus proteins 
have been discussed [3,4] previously in terms of 
'homology' ,  which implies a common ancestor for 
the proteins. When comparing myelin proteins 
with viral proteins, it is difficult to make a com- 
pelling case for homology, since the similarities fall 
of f  after a few residues. While it is not uncommon 
to encounter five or six identical residues in a 
stretch of ten (see table 1), extended regions of 
similar sequence are encountered only rarely. For 
example, although a 55% identity is seen between 
the first 20 residues of the proteolipid and the late 
100 kDa protein of adenovirus 2 or 5, i.e., 
Prolcolipid (1 -20) GIA.E('CA R('I V(;AP.I ASI.VA 
i l l l l  II ! i i~ 
Adenovirus (561-580) GI.I.I;('HCR('NI_(.'TPI, tRSI.VC, 
more likely that the virus and myelin proteins are 
'analogous', i.e., that similar portions arose by 
convergent evolution to a common sequence or 
secondary structure. This idea is consistent with 
the well-known propensity of viruses to undergo 
rapid mutation, particularly of their surface an- 
tigenic sites [13]. 
The tryptophan containing region of MBP has 
long been recognized as being highly 
encephalitogenic [2,5]. In particular, the nonapep- 
tide, Phe-Ser-Trp-Gly-Ala-Glu-Gly-GIn-Lys, has 
been shown to be highly effective in inducing EAE 
in guinea pigs, and studies with peptide analogs in- 
dicate that the essential features of an 
encephalitogenic determinant are X-X-Trp-X-X- 
X-X-Gln/Asn-Lys/Arg. The proteolipid contains 
two regions that have a Trp and a Lys residue 
separated by 5 residues, but otherwise they are not 
remarkably similar to the encephalitogenic MBP 
peptide. It is interesting, however, that one of the 
tryptophans (Trp-144) occurs in a region that 
shows several similarities with viral proteins (table 
1). In the course of our analysis, we also found a 
strong similarity, not previously reported [3], be- 
tween the encephalitogenic MBP protein and the 
gag-pol polyprotein of murine leukemia virus 
(MLV): 
Myelin basic protein (114-123) FSWGAEGQKP 
L I L I I  
gag-pol protein (MLV) (992-1001) FNWGPDQQKA. 
It would not be surprising if antibodies against he 
MLV peptide were found to cross-react with MBP. 
There are now at least two reports of mimicry of 
normal human proteins by viruses: MBP by 
hepatitis B virus polymerase [4] and c~-thymosin 
by the AIDS virus HTLV- I I I /LAV [14]. In addi- 
tion Pruijn et al. [15] have reported that sera from 
patients suffering from autoimmune diseases can 
inhibit adenovirus DNA replication, suggesting a
similar phenomenon. The similarities between viral 
proteins and myelin proteolipid may represent yet 
another case. In this instance, it seems likely that 
portions of the protein which are potential an- 
tigenic determinants are located on the outer sur- 
face of the cell membrane, making it more 
understandable how the cell membrane could come 
under immunological attack. 
the similarity does not extend further. It seems 
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